The House’s Republican Study Committee released a counterproposal to the Senate’s Endless Frontier Act that would call for a host of new sanctions against China, continue U.S. export control authorities and make some changes to the Committee on Foreign Investment in the U.S. The committee’s Countering Communist China Act, released July 29, calls for broad U.S. sanctions actions, including designations against Chinese technology applications, various senior government officials, foreign people that steal U.S. intellectual property and “foreign persons that knowingly spread malign disinformation … for purposes of political warfare.” The Treasury Department’s Office of Foreign Assets Control would also be authorized to hire 10 new employees to “carry out activities of the Office associated with the People’s Republic of China.”

A House lawmaker recently introduced a bill that would add the U.S. agriculture secretary as a member of the Committee on Foreign Investment in the U.S. The Agricultural Security Risk Review Act, which has been previously introduced both in the House and Senate, would allow the U.S. Department of Agriculture to have input in investment transaction reviews, Rep. Frank Lucas, R-Okla., said May 20. The bill comes during a time when foregn ownership of U.S. agricultural businesses is “steadily” increasing, Lucas said. He called the move “long overdue.” “I know firsthand just how important our agriculture industry is, which is why Congress must remove the hurdles that keep USDA from having a permanent seat at the table with CFIUS’ review of foreign transactions," Lucas said.

Republican Sens. Marco Rubio of Florida and John Cornyn of Texas introduced a bill to bolster the ability of U.S. foreign investment reviews to cover genetic information. The Genomics Expenditures and National Security Enhancement Act would require mandatory filings to the Committee on Foreign Investment in the U.S. for “any deal” that involves a company working with genetic information, Rubio said May 20. Under the bill, CFIUS would be required to consult with the Department of Health and Human Services on any deal that involves a “genetic data transaction,” which would increase “cross-agency awareness” of these transactions. The bill would also require CFIUS to include the Senate’s Select Committee on Intelligence and the Foreign Relations Committee in its briefings.

Export Compliance Daily is providing readers with the top stories for April 26-30 in case you missed them. You can find any article by searching on the title or by clicking on the hyperlinked reference number.

The Biden administration will likely build on the U.S.’s recently revised investment screening regulations by expanding the list of countries that qualify as excepted foreign states, trade lawyers said. The Committee on Foreign Investment in the U.S. currently only recognizes Australia, Canada and the United Kingdom as excepted states (see 2002270049) -- a designation that reduces the likelihood that CFIUS will heavily intervene in deals from those countries -- but could soon also recognize Japan, said Richard Sofield, a Wiley Rein trade lawyer.

Export Compliance Daily is providing readers with the top stories for April 19-23 in case you missed them. You can find any article by searching on the title or by clicking on the hyperlinked reference number.

U.S. universities are opposing the Senate’s Strategic Competition Act of 2021 over a provision that would expand foreign investment screening to include foreign gifts over $1 million given to U.S. universities. In a letter to the Senate Foreign Relations Committee this month, four academic groups said the expanded jurisdiction awarded to the Committee on Foreign Investment in the U.S. would subject “many gifts” received by colleges to a CFIUS review and would make it “harder” for colleges to conduct research.

The Senate Foreign Relations Committee passed its comprehensive China bill with several amendments, sending a bill to the Senate floor that could update China-related sanctions, export controls and foreign investment reviews. Senators said they expect the Strategic Competition Act of 2021 -- which would authorize a host of measures to address trade and technology competition issues with China and expand the jurisdiction of the Committee on Foreign Investment in the U.S. (see 2104080066) -- to garner broad bipartisan support before the full Senate.

Despite more scrutiny from the U.S., Chinese foreign direct investment in North America grew by almost half in 2020 compared to 2019, according to an April 19 Baker McKenzie report. But trade and investment experts cautioned industry about placing too much stock in those numbers, saying two-way U.S.-China investment remains “very low” and Chinese firms are still wary about gaining approval from the Committee on Foreign Investment in the U.S.

U.S. measures to expand foreign investment screening are having an increasingly chilling impact on Chinese companies’ willingness to invest in the U.S., said Jingyuan Shi, a media and technology lawyer with Simmons & Simmons. As the Biden administration continues to implement its China strategy, including its administration of the Committee on Foreign Investment in the U.S., some Chinese technology companies “are adopting a wait-and-see attitude,” especially amid the U.S.-China “trade tension atmosphere,” Shi said during a March 24 webinar hosted by the law firm.